News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Strategic Diagnostics Inc. (SDIX) Announces It Has Surpassed $1 Million in "Booked" Genomic Antibody Technology® Projects



1/22/2008 9:18:30 AM

NEWARK, Del.--(BUSINESS WIRE)--Strategic Diagnostics Inc. (Nasdaq:SDIX) – today announced that project bookings for “custom” Genomic Antibody Technology® (GAT) projects exceeded the $1 million dollar mark over the last seven months of 2007. The full-range of GAT offerings were introduced in May of 2007. Since that introduction, the Company has received orders from more than 100 customers including eight of the top 18 pharmaceutical/biotech companies (as ranked by global revenue).

Read at BioSpace.com


comments powered by Disqus
SDIX
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES